Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
10.75
-0.27 (-2.45%)
Jul 23, 2026, 12:28 PM EDT - Market open
Carlsmed Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Carlsmed stock has a consensus rating of "Strong Buy" and an average price target of $18.6. The average 1-year stock price forecast is 73.02% higher than the current stock price, while the lowest is $17 (+58.14%) and the highest is $23 (+113.95%).
Price Target: $18.6 (+73.02%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Carlsmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Initiates $17 | Buy | Initiates | $17 | +58.14% | Jul 1, 2026 |
| BTIG | BTIG | Buy Maintains $23 | Buy | Maintains | $23 | +113.95% | Jun 23, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $18 | Buy | Reiterates | $18 | +67.44% | Jun 3, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $18 | Buy | Reiterates | $18 | +67.44% | May 6, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | +48.84% | May 6, 2026 |
Financial Forecast
Revenue This Year
74.83M
from 50.51M
Increased by 48.15%
Revenue Next Year
104.95M
from 74.83M
Increased by 40.25%
EPS This Year
-1.47
from -1.97
EPS Next Year
-1.44
from -1.47
EPS and Forward PE are based on non-GAAP adjusted numbers.